Followers | 1693 |
Posts | 205052 |
Boards Moderated | 11 |
Alias Born | 01/02/2008 |
Wednesday, December 16, 2015 7:04:08 PM
Roth Capital analyst Philip Shen sees the ITC extension as likely to have a positive impact quite possibly on "nearly all solar stocks." According to Roth Capital's latest equity research notes on solar released Wednesday, ReneSola Ltd. (ADR) (NYSE: SOL), Enphase Energy Inc (NASDAQ: ENPH) and JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) were among some of the solar companies given Buy ratings by the research firm.
'Quite Bullish' On Solar If Deal Is Passed
JA Solar Holdings received a price target of $9.18 from the firm. Roth Capital noted that the extension could lead to higher volumes in the United States, as the company works to expand its presence in the U.S. market (JA Solar recently hired Robert Petrina, the former managing director of Yingli Green Energy Americas).
ReneSola has a target price of $1.70 from the firm. Roth Capital also believes an extension could lead to higher U.S. volumes and opportunities to expand its project business for the company.
Roth Capital has set a target price of $2.41 on Enphase, seeing the company as highly exposed to the U.S. residential solar market.
Recent SOL News
- Emeren Group and Nuveen Infrastructure Finalize 354 MWp Battery Storage Portfolio in Italy with 2.83 GWh Capacity • PR Newswire (US) • 04/23/2024 10:00:00 AM
- Emeren Group Announces Receipt of Notice of Late Filing from NYSE • PR Newswire (US) • 04/19/2024 10:00:00 AM
- Emeren Announces Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 03/28/2024 08:05:00 PM
- US Stock Futures Stable in Pre-Market On Path for Consecutive Quarterly Gains, Oil Prices Rise • IH Market News • 03/28/2024 11:42:00 AM
- Emeren to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024 • PR Newswire (US) • 03/18/2024 09:00:00 PM
- Emeren Group and Glennmont to Develop 155 MW of Battery Storage Projects in Italy • PR Newswire (US) • 03/15/2024 10:00:00 AM
- Emeren Group to Participate at the 36th Annual ROTH Conference • PR Newswire (US) • 03/14/2024 10:00:00 AM
- Emeren Group's Board of Directors Approves an Accelerated Stock Repurchase Program up to $10 million • PR Newswire (US) • 02/12/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:37:21 PM
- Emeren Group Announces Preliminary 2023 Financials and 2024 Outlook • PR Newswire (US) • 01/25/2024 11:00:00 AM
- Emeren Group Successfully Acquired 10.76 MWh Energy Storage Portfolio in China, Entering Virtual Power Plant Market • PR Newswire (US) • 01/09/2024 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:57:56 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 01/05/2024 09:43:06 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 11:27:46 PM
- Emeren Group Releases 2022 Environmental, Social and Governance Report • PR Newswire (US) • 01/03/2024 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 10:43:42 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 10:41:05 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 10:38:42 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 10:35:44 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 10:30:29 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 10:27:41 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 10:23:58 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 10:22:01 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM